PBH 354 Exam #2

0.0(0)
studied byStudied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/103

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 4:55 PM on 10/15/23
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

104 Terms

1
New cards

what are the two types of epidemiology?

descriptive and analytic/scientific

2
New cards

purpose of descriptive studies

  1. to monitor the public’s health

  2. to evaluate the success of intervention programs

  3. to generate hypotheses about causes of disease

3
New cards

types of descriptive studies

  • case reports and series

  • cross-sectional study

  • ecological study

4
New cards

what do descriptive studies do?

identify and count cases of disease in populations according to person, place, and time, and conduct simple studies

5
New cards

purpose of analytic/scientific studies

  1. to evaluate a hypothesis about the causes of disease

  2. to evaluate the success of intervention programs

6
New cards

what do analytic/scientific studies do?

compare group and systematically determine: is there an association?

7
New cards

types of analytic/scientific studies

clinical trial, experimental study, case-control study, and cohort study

8
New cards

what is the goal of epidemiological research?

conduct an epidemiological study to determine the relationship between an exposure of interest and a disease/outcome of interest with validity and precision using a minimum amount of resources

9
New cards

components of a study

  1. population

  2. exposure

  3. outcome

  4. potential confounders

  5. analysis

  6. communication of findings

10
New cards

what is a source population?

the population you are interested in knowing more about

11
New cards

what is a study population?

the population you enroll in your study to represent the source population

12
New cards

what does generalizability mean?

the extent to which the results from a study can be generalized (or extendded) to people who did not participate in the study

13
New cards

case definition

description of the event you are interested in studying; can be a disease, defect, injury, event, state

14
New cards

what is the goal when creating a case definition?

minimize errors

15
New cards

exposure

Determinant of interest upon which an outcome depends; can be constitutional, environmental, or behavioral

16
New cards

examples of constitutional exposures

genetic polymorphism, female sex, short stature

17
New cards

examples of environmental exposures

fluoridated water, air pollution, passive cigarette smoke

18
New cards

examples of behavioral exposures

cigarette smoker, illicit drug user, fitness enthusiast, high fiber diet

19
New cards

goal when determining exposures

minimize errors

20
New cards

cofounders

extraneous determinant of an outcome; can be constitutional, environmental, or behavioral

may lead to distortion of true association between exposure and disease

21
New cards

goal when determining potential confounders

to identify and control them in some way

22
New cards

analysis

examination of your study data; estimation of measures of disease frequency and association

23
New cards

communication of findings

tell the appropriate persons or community what you found even if you found no association

24
New cards

types of experimental analytical scientific studies

  • clinical trial

  • experimental study

25
New cards

types of observational scientific studies

  • cohort study

  • case-control study

26
New cards

experimental study

study preventions and treatments for diseases

randomization normally assigns groups

27
New cards

key feature of an experimental study

Investigator assigns individuals to two or more groups that either do or do not receive a preventative or therapeutic agent and follows the groups for incidence of outcomes

28
New cards

setting of experimental study

  • ethical and feasible

  • small affect expected

  • money is available

29
New cards

incidence of outcome for experimental studies

disease occurence, symptom improvement, survival, side affects r

30
New cards

cohort study purpose

studies causes, preventions, and treatments for diseases

31
New cards

key feature of cohort studies

investigator selects subjects according to their exposure levels and follows them for disease occurrence

32
New cards

setting of cohort study

  • trial not ethical, feasible, or too expensive

  • moderate or large effect expected

  • little known about exposure and so can evaluate many effects of an exposure

  • exposure is rare

33
New cards

how are groups selected in cohort studies

investigator slects exposed and comparison groups e

34
New cards

retrospective

examines past

35
New cards

prospective

examines future

36
New cards

case-control study purpose

studies cause, preventions, and treatments for diseases

37
New cards

key feature of case-control study

method of sampling a population where subjects are identified as having the disease (cases) or are from the source population that gave rise to the cases (controls) and exposure distribution is compared

38
New cards

setting of case-control study

  • trial not ethical, feasible, or too expensive

  • moderate or large effect expected

  • little known about disease and so can evaluate many exposures

  • disease is rare

39
New cards

process of experimental studies

  1. research questions for experimental studies

  2. types of experimental studies

  3. study population

  4. consent, enrollment, exposure assignment

  5. minimizing bias

  6. analysis

40
New cards

equipoise

a state in which investigators truly do not know whether one treatment is better than another, but truly believe withholding treatment, from study participants will not harm them

41
New cards

when is an experimental study ethical

when equipoise is present

42
New cards

types of trials

prevention and therapeutic

43
New cards

prevention trial

agent given to healthy or high-risk individuals to prevent disease occurrence

44
New cards

therapeutic trial

agent given to diseased individuals to treat or cure disease

45
New cards

units of allocation

individual trial and community trial

46
New cards

individual trial

  • treatment allocated to individuals

  • ex: study effectiveness of treatment with two drugs versus three drugs among adults infected with HIV

47
New cards

community trial

  • treatment allocated to entire community

  • ex: study impact of drinking water fluoridation on frequency of dental caries in one community vs no fluoridation in similar community

48
New cards

population hierarchy

reference population —> experimental source population (potential participants) —> study population —>informed consent allocation —> treatment and comparison group

49
New cards

sample size is necessary because…

to determine a true difference between treatment and comparison groups, enrollment of an adequate number of study subjects is necessary

50
New cards

statistical power

ability to demonstrate an association

80% or greater = good power

51
New cards

consent process, enrollment, exposure assignment

  1. IRB must approve the study protocol

  2. The investigator submits a detailed protocol

  3. must demonstrate informed consent, privacy and confidentiality, minimization of risks, special protections of vulnerable subjects, and fairness of selection study subject

  4. PARTICIPANTS MUST GIVE INFORMED CONSENT

52
New cards

informed consent

clear expectation of research goals and methods, risks and benefits of participating, assurance of confidentiality, right to withdraw, etc.

53
New cards

randomization

each study participant has the same probability of receiving treatment

54
New cards

how does randomization affect confounding variables

minimizes affect

55
New cards

when does randomization work best

  • The study is large enough

  • treatment assignment is not influenced by investigator

56
New cards

blinding/masking

method of ensuring that participants and/or study investigators have no knowledge of whether a study participant has been assigned to the treatment or comparison group

57
New cards

single blind

study participant does not whether he or she is receiving treatment or no treatment

58
New cards

double blind

neither the study participant nor the study investigator administrating the treatment knows who is receiving treatment or no treatment

59
New cards

triple blind

neither the study partipant, not the study investigator, nor the investigator monitoring the effects of the treatment knows who is receiving treatment or no treatment

60
New cards

ways to minimize bias

  • placebo

  • compliance

61
New cards

noncompliance makes the study….

more alike

non compliance tends to bias toward the “null'“

62
New cards

cohort study

a study in which people who are free of disease and that differ according to exposure are followed over time for incidence of disease

“natural experiment”

63
New cards

cons of prospective cohort study

  • more expensive, time consuming

  • not efficient for disease with long laten periods

64
New cards

pros for prospective cohort study

  • better exposure and cofounder data

  • less vulnerable to bias

65
New cards

pros for retrospective cohort study

  • cheaper, faster

  • efficient with disease with long latent period

66
New cards

cons for retrospective cohort study

  • exposure and confounder data may be inadequate

  • more vulnerable to bias

67
New cards

ambidirectional cohort study

contains elements of both prospective and retrospective types of studies

68
New cards

types of cohorts

general and special

69
New cards

general cohorts

investigate exposures that are common in the general population

study multiple exposures on one or more outcomes

70
New cards

special cohorts

investigate unusual and rare exposures

researchers can study effects of single exposure on one or more outcomes

71
New cards

Framingham Heart Study

  • objective: identify characteristics that contribute to CVD by following healthy individuals

  • 5,209 men and women between 30-62 years old recruited

  • 1948 first generation

  • 1971 second generation

  • 2002 third generation

72
New cards

Air Force Ranch Hand Study

  • 11 million gallons of herbicides sprayed from 1962 to 1971 in Vietnam

  • airmen and the local population were exposed

73
New cards

counterfactual ideal

ideal comparison group would be the exact same people who are in the exposed group had they not been exposed —> epidemiologist select different sets of people who are as similar as possible

74
New cards

types of comparison groups

  • internal

  • comparison cohort

  • general population i

75
New cards

internal

within one type of population

ex: nurses

76
New cards

comparison cohort

two different group

ex: landscapers and construction workers

77
New cards

general population

a subgroup compared to the general population

78
New cards

healthy worker effect

rates of morbidity and mortality among the working population are lower than those of the general population —> leads to underestimation of risk when comparing a worker population to the general population

79
New cards

what type of comparison group leads to the “healthy worker effect”

general population comparison

80
New cards

high levels of loss to follow up can….

result in a bias

81
New cards

how much loss to follow up is okay

less than 80%

82
New cards

strengths of cohort studies

  • clear temporal sequence between E and D, especially if prospective

  • efficient for rare exposures

  • goof information on exposures, confounders, especially if prospective

  • can study effects of an exposure on multiple outcomes

83
New cards

limitations of cohort studies

  • may need large numbers of subjects to be followed for long period of time

  • can be expensive and time-consuming

  • not good for rare diseases or those with long latency, if prospective

  • LTF has potential to undermine validity

84
New cards

what is a solution to cohort studies?

case-control studies

85
New cards

case-control studies

  • a study in which cases of disease are identified, and then a sample of the population that produced the cases is identified

  • exposures are determined and compared for individuals in each group

86
New cards

process of case-control studies

  1. define the study hypothesis

  2. define the source population

  3. identify the cases from the source population

  4. identify valid controls from the same source population

  5. ascertain exposure for cases and controls

  6. calculate a measure of association between exposure and outcome

87
New cards

requirements for control selection

  1. controls must come from the same source population as the cases

  2. controls must be selected independently of exposure

88
New cards

would criterion

if the controls had experienced the outcome, would they have been identified as cases in your study

89
New cards

odds ratio

relative measure of association

NO absolute measures of association can be calculated

90
New cards

risk of illness among exposed

developed disease/ exposed persons

91
New cards

odds of illness among exposed

developed disease/remaining healthy

92
New cards

odds ratio formula

(a/c)/(b/d)

93
New cards

interpretation of odds ratio calculation

compared to unexposed subject, exposed subjects have a ___ times the odds of getting the disease

94
New cards

no association for odds ratio

OR = 1

95
New cards

increased odds

OR>1

96
New cards

decreased odds

OR<1

97
New cards
98
New cards
99
New cards
100
New cards